Back to funds

Catalio Capital Management, LP

hedge fundUpdated 64 days ago

Managed by Catalio Capital Management, Lp • Latest filing Q2 2026

Portfolio value
$532.1M
Q2 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-2.2%
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q3 2025$540.9M
Q4 2025$565.8M
Q1 2026$478.7M
Q2 2026$532.1M

Top holdings

45 positions as of Q4 2025

View filing
G

GILEAD SCIENCES INC

Value
$35.5M
Shares
289.3K
% Port
6.28%
C

BRISTOL-MYERS SQUIBB CO

Value
$34.9M
Shares
647.9K
% Port
6.18%
B

BOSTON SCIENTIFIC CORP

Value
$34.4M
Shares
360.4K
% Port
6.07%
B

BRIDGEBIO PHARMA INC

Value
$31.4M
Shares
410.7K
% Port
5.55%
L

ELI LILLY & CO

Value
$27.9M
Shares
25.9K
% Port
4.92%
D

DIANTHUS THERAPEUTICS INC

Value
$26.9M
Shares
653.6K
% Port
4.76%
A

ASCENDIS PHARMA A/S

Value
$25.4M
Shares
119.3K
% Port
4.50%
S

SYNDAX PHARMACEUTICALS INC

Value
$25.1M
Shares
1.20M
% Port
4.44%
J

JOHNSON & JOHNSON

Value
$25M
Shares
120.8K
% Port
4.42%
R

REGENERON PHARMACEUTICALS

Value
$23M
Shares
29.8K
% Port
4.07%
G

STRUCTURE THERAPEUTICS INC

Value
$17.6M
Shares
252.9K
% Port
3.11%
?
12.N/A

SOLENO THERAPEUTICS INC

Value
$16.7M
Shares
360.3K
% Port
2.95%
C

CYTOKINETICS INC

Value
$16.4M
Shares
258.4K
% Port
2.90%
E

EDWARDS LIFESCIENCES CORP

Value
$15.9M
Shares
187.0K
% Port
2.82%
I

INTUITIVE SURGICAL INC

Value
$15.4M
Shares
27.2K
% Port
2.72%
N

NATERA INC

Value
$14.3M
Shares
62.3K
% Port
2.52%
A

ADAPTIVE BIOTECHNOLOGIES COR

Value
$13.3M
Shares
821.2K
% Port
2.36%
A

ABIVAX SA

Value
$13.3M
Shares
98.5K
% Port
2.35%
S

SUPERNUS PHARMACEUTICALS INC

Value
$12.8M
Shares
257.5K
% Port
2.26%
G

FRACTYL HEALTH INC

Value
$12.1M
Shares
5.49M
% Port
2.14%

Explore